Research summary, narrative review, 2012

Reproductive effects of low to moderate medical radiation exposure

Latini G, Dipaola L, Mantovani A, Picano E. Current medicinal chemistry. 2012

Read the original paper

In plain language

This review estimates that interventional cardiologists receive about 50 to 100 microSv gonad dose under the apron per procedure, adding up to 0.5-1 Sv over a career, but evidence linking such doses to reproductive harm remains inconclusive.

At a glance

Type of study
Narrative review
Who was studied
Interventional cardiologists, Interventional radiologists, Patients
Summary based on
the abstract

What it found

  • In interventional cardiologists, gonad dose under the lead apron is similar in magnitude to the shielded thyroid dose, about 50 to 100 microSv per cine-angiography procedure, and up to ten-fold higher for complex procedures.

    Key figures: median 50 to 100 microSievert per procedure; ten-fold higher for complex procedures

  • Cumulative gonad exposure over a 30-year career is estimated at 0.5-1 Sv.

    Key figures: 0.5-1 Sv over 30 years

  • Epidemiological evidence on reproductive effects at low-to-moderate doses is inconclusive and inadequate for evidence-based advice.

  • Interventional cardiology and radiology staff have professional exposures two to three times higher than diagnostic radiologists.

    Key figures: two-to three times higher

  • Biomarkers of reproductive health (hormones, sperm quality, sperm DNA damage) are proposed for future research.

    Key figures: < 1000 mSv

Limits to keep in mind

Narrative review summarised from the abstract only; dose figures are estimates compiled from other studies, and the health evidence reviewed is described as inconclusive.

How this summary was made

ORSIF prepared this summary with AI assistance from the abstract of the paper. A program then checked that the passage supporting each finding appears word for word in that source. A person has not yet reviewed each summary, so read the original before relying on a number. ORSIF summarizes research and does not endorse any product or company. Report a problem with this summary.

Prepared November 3, 2026.